Urteste SA Total Liabilities
Urteste SA total liabilities. Based on the latest financial reports, Urteste SA (URT) has total liabilities worth zł16.75 Million PLN (≈ $4.61 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Urteste SA's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Urteste SA (2019–2025)
Total liabilities of Urteste SA from 2019 to 2025. This chart illustrates how Urteste SA's total liabilities have evolved over time, based on quarterly financial data.
Urteste SA Competitors by Total Liabilities
The table below lists competitors of Urteste SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wicaksana Overseas International
JK:WICO
|
Indonesia | Rp386.32 Billion |
|
Kota Satu Properti Tbk PT
JK:SATU
|
Indonesia | Rp164.80 Billion |
|
Primega Group Holdings Limited Ordinary Shares
NASDAQ:PGHL
|
USA | $9.08 Million |
|
Rajshree Polypack Limited
NSE:RPPL
|
India | Rs1.62 Billion |
|
Zodiac Energy Limited
NSE:ZODIAC
|
India | Rs-965.64 Million |
|
Anoto Group AB
ST:ANOT
|
Sweden | Skr119.07 Million |
|
Samyang Holdings Corp
KO:000075
|
Korea | ₩2.29 Trillion |
|
Superhouse Limited
NSE:SUPERHOUSE
|
India | Rs3.73 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Urteste SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Urteste SA's balance sheet.
Liquidity & Leverage Metrics
Urteste SA Total Liabilities Ratios Explained
Urteste SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Urteste SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Urteste SA (2019–2025)
The table below shows the annual total liabilities of Urteste SA from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | zł10.56 Million ≈ $2.91 Million |
+91.76% |
| 2024-12-31 | zł5.51 Million ≈ $1.52 Million |
+196.87% |
| 2023-12-31 | zł1.85 Million ≈ $510.52K |
+72.88% |
| 2022-12-31 | zł1.07 Million ≈ $295.31K |
+325.72% |
| 2021-12-31 | zł252.04K ≈ $69.37K |
+1284.40% |
| 2020-12-31 | zł18.21K ≈ $5.01K |
-58.64% |
| 2019-12-31 | zł44.02K ≈ $12.12K |
-- |
About Urteste SA
Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.